[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-6a2b26e3-b59c-4699-9be7-4b1f945a34aa--":3,"related-articles-undefined-undefined-bbbe2d26-551c-4817-949f-572d06875acf-true":382},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"videoUrl":13,"imageUrls":14,"city":16,"website":17,"orgId":18,"branches":19,"description":381},"6a2b26e3-b59c-4699-9be7-4b1f945a34aa","PRESSRELEASE","Nederland vaardigt Micreos af naar halve finale Ideas from Europe","2017-09-11T10:05:09.446+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fbbbe2d26-551c-4817-949f-572d06875acf\u002Fe9ad6571-aeba-48f0-963a-5fe56ac6b039.jpg","Binnenland","Micreos",false,"\u003Cp>\u003Cstrong>\u003Cem>Den Haag, 11 september 2017\u003C\u002Fem>\u003C\u002Fstrong>\u003Cstrong>- Biotechnologiebedrijf Micreos, dat een alternatief voor antibiotica heeft ontwikkeld, zal Nederland op 22 november 2017 vertegenwoordigen tijdens de halve finale van \u003Cem>Ideas from Europe\u003C\u002Fem> in Estland (het Eurovisie Songfestival voor innovatie). In aanwezigheid van voormalig VN-secretaris-generaal Kofi Annan en minister Melanie Schultz van Infrastructuur & Milieu, werd Micreos gekozen uit 17 finalisten. Jury-voorzitter Kasja Ollongren, loco-burgemeester van Amsterdam, benadrukt de impact die Micreos' product voor miljoenen mensen kan hebben.\u003C\u002Fstrong>\u003Cstrong> \u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>Het Making Waves-congres op de Afsluitdijk werd bijgewoond door honderden beleidsmakers, ondernemers, investeerders en ontwikkelaars. De 17 finalisten introduceerden hun innovatie voor een publiek van zeshonderd personen.  \u003C\u002Fp>\n\u003Cp>Eregast Kofi Annan, winnaar van de Nobelprijs voor de Vrede, was enthousiast: \"Ik ben zeer onder de indruk van Micreos' alternatief voor antibiotica”, zo zei hij.\u003C\u002Fp>\n\u003Cp>Volgens jury-voorzitter Kasja Ollongren viel de keuze van de jury op Micreos omdat de technologie van het bedrijf al is ontwikkeld en inmiddels tienduizenden mensen helpt. “De jury is ervan overtuigd dat Micreos' alternatief voor antibiotica 'life-changing' kan zijn voor miljoenen mensen.” \u003C\u002Fp>\n\u003Cp>Micreos CEO Mark Offerhaus is verheugd: “Antibiotica-resistentie is een enorm mondiaal probleem. Wij zijn vereerd met alle waardering. Met ons product Gladskin helpen we al mensen met huidaandoeningen als eczeem, acne, en rosacea en diabetische wondinfecties, veroorzaakt door de bacterie \u003Cem>Staphylococcus aureus\u003C\u002Fem>, inclusief de resistente MRSA. Maar dat is wat ons betreft slechts het begin. Onze endolysine-technologie biedt een écht alternatief dat nu al benut kan worden en nog veel meer kan betekenen. Daarbij hebben we geen tijd te verliezen.\"\u003C\u002Fp>\n\u003Cp>Micreos zal Nederland vertegenwoordigen met het meest innovatieve idee in de halve finale van \u003Cem>Ideas from Europe\u003C\u002Fem> in Estland, op 22 november 2017.  \u003C\u002Fp>\n\u003Cp>\u003Cstrong>Over Ideas from Europe \u002F Making Waves\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>\u003Cem>Ideas from Europe\u003C\u002Fem> is een Europees platform ter bevordering van de ontwikkeling van ideeën voor vraagstukken met grote sociale en economische gevolgen. Het platform komt in november bijeen in Estland, tijdens het Europees voorzitterschap van dit land.  De gedachte achter \u003Cem>Ideas from Europe \u002F Making Waves\u003C\u002Fem> is dat relevante doorbraken het publiek sneller zullen bereiken als een grote groep mensen er breed over communiceert.\u003C\u002Fp>\n\u003Cp> Zie: https:\u002F\u002Fideasfrom.eu\u002F en https:\u002F\u002Fmakingwavesnl.nl\u002F\u003C\u002Fp>\n\u003Cp> \u003Cstrong>Over Micreos\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>Micreos ontwikkelt endolysine- en fagentechnologie die voor het eerst alleen ongewenste bacteriën doodt. Micreos wordt beschouwd als leidende speler op dit gebied. De onderneming heeft een eigen productie- en R&D-centrum voor endolysines in Bilthoven. Voor fagen ten behoeve van voedselveiligheid en landbouw heeft Micreos een technolgiecentrum voor onderzoek, ontwikkeling en productie in Wageningen. Het hoofdkantoor is gevestigd in Den Haag. Het bedrijf werkt samen met ETH Zurich en vele Nederlandse medische centra, waaronder het EMCR (Rotterdam). Gladskin is een product van Micreos Human Health. Micreos Food Safety produceert de door de FDA erkende producten PhageGuard L (\u003Cem>Listeria\u003C\u002Fem>), en S (\u003Cem>Salmonella\u003C\u002Fem>).\u003C\u002Fp>\n\u003Cp>\u003Cstrong>WATCH: de winnende pitch van 4 minuten door CEO Mark Offerhaus \u003C\u002Fstrong>https:\u002F\u002Fwww.youtube.com\u002Fwatch?v=rArLm346ZQA&t=1s  \u003C\u002Fp>","https:\u002F\u002Fwww.youtube.com\u002Fwatch?v=rArLm346ZQA&t=1s  ",[15],"https:\u002F\u002Flh3.googleusercontent.com\u002FUsYreZazsY4t79fZCAWFKJvDOK1EIscyVjvRKF_saaEYcXB31OHTjDoJFX2jw-qp9vp42T5s_q-dMQK3-VPQ5OFezHMxDzPo","Den Haag","http:\u002F\u002Fwww.micreos.com\u002F","bbbe2d26-551c-4817-949f-572d06875acf",[20,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81,84,87,90,93,96,99,102,106,109,112,115,118,121,124,127,130,133,136,139,142,145,148,150,153,156,159,162,165,168,171,174,177,180,183,186,189,192,195,198,201,204,207,210,213,216,219,222,225,228,231,234,237,240,243,246,249,252,255,258,261,264,267,270,273,276,279,282,285,289,292,295,298,301,304,307,310,313,316,319,322,325,329,332,335,338,341,344,347,350,352,355,359,362,365,369,372,375,378],{"id":21,"title":22,"parentId":23},"29183","Medisch specialisme","29100",{"id":25,"title":26,"parentId":23},"29127","Aflevering van geneesmiddelen",{"id":28,"title":29,"parentId":23},"29186","Afslanken en dieetleer",{"id":31,"title":32,"parentId":23},"29102","Alcoholisme en drugsmisbruik",{"id":34,"title":35,"parentId":23},"29103","Allergologie",{"id":37,"title":38,"parentId":23},"29104","Alternatieve geneeskunde",{"id":40,"title":41,"parentId":23},"29105","Ambulancediensten",{"id":43,"title":44,"parentId":23},"93242","Andrologie",{"id":46,"title":47,"parentId":23},"29106","Anesthesie",{"id":49,"title":50,"parentId":23},"93172","Aromatherapie",{"id":52,"title":53,"parentId":23},"29118","Gezondheidszorg",{"id":55,"title":56,"parentId":23},"29109","Bio-informatica",{"id":58,"title":59,"parentId":23},"29111","Cardiologie",{"id":61,"title":62,"parentId":23},"29114","Chiropodie",{"id":64,"title":65,"parentId":23},"29115","Chiropraxie",{"id":67,"title":68,"parentId":23},"29190","Chirurgie",{"id":70,"title":71,"parentId":23},"29119","Computers in gezondheidszorg",{"id":73,"title":74,"parentId":23},"29122","Dermatologie",{"id":76,"title":77,"parentId":23},"29126","Geneesmiddelen",{"id":79,"title":80,"parentId":23},"29123","Diabetes",{"id":82,"title":83,"parentId":23},"29124","Diagnostiek",{"id":85,"title":86,"parentId":23},"29135","Eerste hulp",{"id":88,"title":89,"parentId":23},"29128","Eetstoornissen",{"id":91,"title":92,"parentId":23},"29129","Endocrinologie",{"id":94,"title":95,"parentId":23},"29130","Epidemiologie",{"id":97,"title":98,"parentId":23},"29131","Experimentele geneeskunde",{"id":100,"title":101,"parentId":23},"29134","Huisartsen",{"id":103,"title":104,"parentId":105},"29136","Fitness","49100",{"id":107,"title":108,"parentId":23},"29175","Fysiologie",{"id":110,"title":111,"parentId":23},"29176","Fysiotherapie",{"id":113,"title":114,"parentId":23},"29137","Gastro-enterologie",{"id":116,"title":117,"parentId":23},"29120","Gehoor en spraak",{"id":119,"title":120,"parentId":23},"29159","Geneeskunde",{"id":122,"title":123,"parentId":23},"29113","Geneeskunde bij ongevallen",{"id":125,"title":126,"parentId":23},"29160","Geneeskunde en uitrusting in het buitenland",{"id":128,"title":129,"parentId":23},"29179","Geneesmiddelen op voorschrift",{"id":131,"title":132,"parentId":23},"29139","Gerontologie",{"id":134,"title":135,"parentId":23},"29132","Gezinsplanning",{"id":137,"title":138,"parentId":23},"29141","Gezondheid",{"id":140,"title":141,"parentId":23},"29200","Gezondheidsbeheer",{"id":143,"title":144,"parentId":23},"93782","Gezondheidsbeleid",{"id":146,"title":147,"parentId":23},"29142","Gezondheidsonderwijs",{"id":149,"title":53,"parentId":23},"29143",{"id":151,"title":152,"parentId":23},"29101","HIV en AIDS",{"id":154,"title":155,"parentId":23},"29140","Hematologie",{"id":157,"title":158,"parentId":23},"29144","Holistische geneeskunde",{"id":160,"title":161,"parentId":23},"29145","Homeopathie",{"id":163,"title":164,"parentId":23},"29138","Mantelzorg",{"id":166,"title":167,"parentId":23},"29148","Hypnose",{"id":169,"title":170,"parentId":23},"29149","Immunologie",{"id":172,"title":173,"parentId":23},"29151","Intensive care",{"id":175,"title":176,"parentId":23},"29125","Invaliditeit en revalidatie",{"id":178,"title":179,"parentId":23},"29173","Keel-, neus- en oorheelkunde",{"id":181,"title":182,"parentId":23},"29116","Klinische geneeskunde",{"id":184,"title":185,"parentId":23},"29117","Klinische testen",{"id":187,"title":188,"parentId":23},"29107","Kunstmatige weefsels",{"id":190,"title":191,"parentId":23},"29152","Leverziekten",{"id":193,"title":194,"parentId":23},"29153","Longziekten",{"id":196,"title":197,"parentId":23},"93772","Medicijnenbeleid",{"id":199,"title":200,"parentId":23},"29154","Medische en ziekenhuisuitrusting",{"id":202,"title":203,"parentId":23},"94192","Medische esthetiek",{"id":205,"title":206,"parentId":23},"29157","Medische producten en diensten",{"id":208,"title":209,"parentId":23},"29155","Medische specialisten",{"id":211,"title":212,"parentId":23},"29158","Medische technologie",{"id":214,"title":215,"parentId":23},"29156","Medische-praktijkbeheer",{"id":217,"title":218,"parentId":23},"29161","Mentale gezondheid",{"id":220,"title":221,"parentId":23},"29163","Nefrologie",{"id":223,"title":224,"parentId":23},"29164","Neurologie",{"id":226,"title":227,"parentId":23},"29166","Nucleaire geneeskunde",{"id":229,"title":230,"parentId":23},"29169","Obstetrie en gynaecologie",{"id":232,"title":233,"parentId":23},"29150","Onafhankelijke gezondheidssector",{"id":235,"title":236,"parentId":23},"29110","Oncologie",{"id":238,"title":239,"parentId":23},"94822","Oogverzorging",{"id":241,"title":242,"parentId":23},"94802","Optica",{"id":244,"title":245,"parentId":23},"29170","Opticiens en oftalmologie",{"id":247,"title":248,"parentId":23},"94812","Optische technologie",{"id":250,"title":251,"parentId":23},"29171","Orthopedie",{"id":253,"title":254,"parentId":23},"29172","Ostheopathie",{"id":256,"title":257,"parentId":23},"29112","Ouderenzorg",{"id":259,"title":260,"parentId":23},"29174","Kindergeneeskunde",{"id":262,"title":263,"parentId":23},"29177","Plastische chirurgie",{"id":265,"title":266,"parentId":23},"29180","Psychiatrie en psychotherapie",{"id":268,"title":269,"parentId":23},"29181","Radiologie en radiografie",{"id":271,"title":272,"parentId":23},"29184","Reumatologie",{"id":274,"title":275,"parentId":23},"29182","Langdurige zorg",{"id":277,"title":278,"parentId":23},"29108","Rugpijn",{"id":280,"title":281,"parentId":23},"29188","SOA's",{"id":283,"title":284,"parentId":23},"29185","Seksuele gezondheid",{"id":286,"title":287,"parentId":288},"93162","Wellness","91000",{"id":290,"title":291,"parentId":23},"29187","Sportgeneeskunde",{"id":293,"title":294,"parentId":23},"29189","Stressbeheer",{"id":296,"title":297,"parentId":23},"29121","Tandheelkunde",{"id":299,"title":300,"parentId":23},"29191","Telegeneeskunde",{"id":302,"title":303,"parentId":23},"29165","Toepassingen voor nieuwe geneesmiddelen",{"id":305,"title":306,"parentId":23},"29192","Toxicologie",{"id":308,"title":309,"parentId":23},"29193","Transplantaties",{"id":311,"title":312,"parentId":23},"29194","Traumatologie",{"id":314,"title":315,"parentId":23},"93232","Tropische ziekten",{"id":317,"title":318,"parentId":23},"29195","Urologie",{"id":320,"title":321,"parentId":23},"29196","Vaccins",{"id":323,"title":324,"parentId":23},"29167","Verpleegkundigen",{"id":326,"title":327,"parentId":328},"29198","Vitamines en voedingssupplementen","13100",{"id":330,"title":331,"parentId":328},"29168","Voeding",{"id":333,"title":334,"parentId":23},"29162","Vroedvrouwen",{"id":336,"title":337,"parentId":23},"29133","Vruchtbaarheid en voortplanting",{"id":339,"title":340,"parentId":23},"29199","Yoga",{"id":342,"title":343,"parentId":23},"29146","Ziekenhuisartsen",{"id":345,"title":346,"parentId":23},"29147","Ziekenhuizen",{"id":348,"title":349,"parentId":23},"29178","Zwangerschap",{"id":23,"title":351},"Zorg",{"id":353,"title":354},"12109","Arbeidsmarkt en ondernemen",{"id":356,"title":357,"parentId":358},"12103","Bedrijven","12100",{"id":360,"title":361,"parentId":358},"12155","Bedrijven, beheer en industrie - andere",{"id":363,"title":364,"parentId":353},"12140","Regionaal bedrijfsnieuws",{"id":366,"title":367,"parentId":368},"594aba81-f219-42c2-8dd7-9d3cd0547682","Dagbladen","38100",{"id":370,"title":371,"parentId":368},"0ab0e99b-345d-43b7-95ce-a4268e20a02c","Online",{"id":373,"title":374,"parentId":368},"90528a49-b59e-4a39-8a47-2f77067c302f","Nationaal nieuws - radio",{"id":376,"title":377,"parentId":368},"69d90a55-c180-4ff9-9da2-4c276aefadf5","Nationaal nieuws TV",{"id":379,"title":380,"parentId":368},"38105","Nieuws - andere","Den Haag, 11 september 2017- Biotechnologiebedrijf Micreos, dat een alternatief voor antibiotica heeft ontwikkeld, zal Nederland op 22 november 2017 vertegenwoo",[383,395,408,419,428,437,449,464,474,484],{"id":384,"title":385,"pubDate":386,"logoUrl":387,"thirdParty":11,"imageUrls":388,"orgId":18,"branches":390,"description":394},"e6ab4c63-6158-414c-8961-2eda46bdad90","Europese Commissie kent Strategisch Project-status toe","2026-10-09T12:07:12.534+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fbbbe2d26-551c-4817-949f-572d06875acf\u002Fe6cd6cf6-da76-459d-a85a-213378a48310.jpg",[389,389],"https:\u002F\u002Flh3.googleusercontent.com\u002FFqX27fpeqJweCJ81DlB6mu_L9VUs_f06_ARDFFX9LYTcJ093OTsJstHxZW4xqoFQ5VH16OcSghowV_Yd9AybYXrYmjTK3gFkmg",[391],{"id":392,"title":393},"51000","Bouw en techniek","Erkenning voor Urban Mining Factory \u002F Printed Circuit Boards van CRITICAL. Erkenning onder de Critical Raw Materials Act ondersteunt de ontwikkeling van Europes",{"id":396,"title":397,"pubDate":398,"logoUrl":399,"thirdParty":11,"imageUrls":400,"orgId":18,"branches":403,"description":407},"cb12a625-7533-4427-8e6d-280933f6a548","Van Maker tot Majesteit geopend: De Koninklijke Troon in de stad waar zijn verhaal begon","2026-10-08T16:29:56.694+02:00","",[401,402,401,402],"https:\u002F\u002Flh3.googleusercontent.com\u002FExLqU20OzHHsb5ak13QQJu3bjN-MV7oJYFiYaVRMVK5IgdA2vB-ZqIK7-O_FzBttEWKp5heNEU9y1jm1MB3s35E2VFWQGLNYcg","https:\u002F\u002Flh3.googleusercontent.com\u002FAoFg_xmHjKOwBijpHkAZR3s4bvt6t4LOFEJZa_LslUZwQ8Z7FfDV5FCFjJLOzqZ4L0_F3PUe63Sv8eP1IZFg9US0HRTFlIhpB1g",[404],{"id":405,"title":406},"17100","Kunst en cultuur","De Koninklijke Troon is in Roermond, de stad waar zijn verhaal begon. Vandaag is in het Cuypershuis de tentoonstelling Van Maker tot Majesteit officieel geopend",{"id":409,"title":410,"pubDate":411,"logoUrl":412,"thirdParty":11,"imageUrls":413,"orgId":18,"branches":415,"description":418},"252cdb6d-aa2b-4f26-b8c3-e2b4908bbe78","Stop verspreiding seksueel kindermisbruik: politiek moet bedrijven verplichten","2026-10-08T06:00:00.037+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fbbbe2d26-551c-4817-949f-572d06875acf\u002F2211e0c5-e548-4ae8-802e-529b1e72ad8b.jpg",[414,414],"https:\u002F\u002Flh3.googleusercontent.com\u002F56K5GlXFKvMKCJrgP7-J2ZEFyI-w-njKzGicUZijvXDZB3Rpj9VMCpmbLAkkQCZr9hseaOz0LyLFxg-edzL3SS48gydL5E-B",[416],{"id":368,"title":417},"Algemeen nieuws","Free a Girl, Defence for Children Nederland, Terre des Hommes en International Justice Mission starten campagne met eis voor minister David van Weel Iedere dag ",{"id":420,"title":421,"pubDate":422,"logoUrl":399,"thirdParty":11,"imageUrls":423,"orgId":18,"branches":425,"description":427},"cc7d184f-e8e5-4583-afde-f4faf3f7f586","Moore wordt Auren samen met Europese partnerkantoren","2026-10-07T10:00:00.037+02:00",[424,424],"https:\u002F\u002Flh3.googleusercontent.com\u002FF9Qf3nWceUWKekv9VosoHqm3He1SjWYbG5mc1ygb7KzQglwswMt6r-D-yzppSURBkrveg2fteHV9xf3qZEKpKeMs60npVgGB",[426],{"id":353,"title":354},"De Nederlandse accountantskantoren Moore DRV en Moore MKW gaan in maart 2027 verder onder de naam Auren. Ook de samenwerkingspartners uit België, Duitsland, het",{"id":429,"title":430,"pubDate":431,"logoUrl":399,"thirdParty":11,"orgId":18,"branches":432,"description":436},"aee27cd0-5cb0-459a-85ee-68a597724762","Bijna 20 jaar na de start vernieuwt Wilgraaghebben.nl volledig voor de feestdagen","2026-10-06T16:22:43.670+02:00",[433],{"id":434,"title":435},"11000","Pr, marketing, communicatie en sales","Nederlands platform voor gratis verlanglijstjes krijgt nieuwe technische basis, nieuwe functies en cadeautips voor alle leeftijden en budgetten Wilgraaghebben.n",{"id":438,"title":439,"pubDate":440,"logoUrl":441,"thirdParty":11,"imageUrls":442,"orgId":18,"branches":444,"description":448},"3e12acf6-951f-4566-867a-6f9675d633a1","Merlon lanceert als eerste 100% Europees soevereine cybersecurity in Nederland","2026-10-06T13:00:00.033+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fbbbe2d26-551c-4817-949f-572d06875acf\u002Fcaaf5550-cc71-402b-83fd-64bab71c0419.jpg",[443,443],"https:\u002F\u002Flh3.googleusercontent.com\u002FGkwDOwxKn3A582olA7DCNT_ITCLY3cAr2k8XXy6yygMGaZCxL006w06M6CAibz5wrvv6JpFHq0UpJxywlp9C8K7bnHc9-p1V",[445],{"id":446,"title":447},"16100","IT, tech en social media","Merlon gaat vandaag live op de ONE Conference in Den Haag. Het is de eerste cybersecurity partij die een stack en dienst levert waarvan eigendom, zeggenschap en",{"id":450,"title":451,"pubDate":452,"logoUrl":399,"thirdParty":11,"imageUrls":453,"orgId":18,"branches":459,"description":463},"c6459b05-b785-4835-8960-ae3fa47d51ab","Poetcore: romans inspireren dé herfstmodetrend van 2026","2026-10-06T10:33:59.370+02:00",[454,455,456,457,458,454,455,456,457,458],"https:\u002F\u002Flh3.googleusercontent.com\u002FSaGy9Cun1MoogHl2DE9N36ft-d_I7np7S0UapibJ5m0DbLeR60s3gDxlS9oItk9AzVvgwBeFJIbPJX9DSiVi6SeGKzT_Jg-DxA","https:\u002F\u002Flh3.googleusercontent.com\u002FgIcAzgJ_fUZy-ytLoe-VFB7STA0jKv5nE7P1WUQ8F21Kn90ZvGLXv75fPiqB-h_q24zlaiTIuf0NqQUJ3sFaSx7jlezH8ELWfA","https:\u002F\u002Flh3.googleusercontent.com\u002FmKCLOkVEHf3gtmGz8wi0o77yVOXSnVR2ZNRB7x6tLF9vXdwlETdcNMeu49Gqxe27LYFludXGbWL180xQI2hcQzfoM8ulGKBIfQ","https:\u002F\u002Flh3.googleusercontent.com\u002F9uvSwXCCbFo5HJYxXryZDQpSPmZ4YG6SIbEyopcnDPWJUQn6kNZdTIRlBRKZK4j5dHFamuGu1TIXijk8blkqvAA0Et6TLxO01g","https:\u002F\u002Flh3.googleusercontent.com\u002F58n3ZxOv4AMJrjpcu6lTpOz4Z0sQ-oU2PNH2CO900A-9c0IAcpIBCC-pSeMkj4xV9fbGFlBBV55tfje0EApfT1iLFD9DUKrJvg",[460],{"id":461,"title":462},"34119","Diversiteit, lifestyle en mode","Het minimalisme en de ingehouden elegantie van de afgelopen jaren zijn passé: deze herfst maakt Poetcore zijn intrede. De trend is een mix van romantiek, indivi",{"id":465,"title":466,"pubDate":467,"logoUrl":468,"thirdParty":11,"imageUrls":469,"orgId":18,"branches":471,"description":473},"8b4aed6c-a36f-487a-8a6b-7a5c5680675d","ORTEC vermeld als representatieve leverancier in Gartner® Market Guide for VRS 2026","2026-10-07T09:00:00.028+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fbbbe2d26-551c-4817-949f-572d06875acf\u002Fcf3b6dfd-b1f8-4e55-8d9c-dd61f9fe0b75.jpg",[470,470],"https:\u002F\u002Flh3.googleusercontent.com\u002Fgs3i_IOsqUsogv5wtcQ7IYy0lhMlBIPJa5Wyeq4pfpSYVDzrJeQfEgAedHwSRWI38bmXqrwYiDNkq5rQwbBUuMR0ib8YrkOaaQ",[472],{"id":368,"title":417},"ORTEC vermeld als representatieve leverancier in Gartner® Market Guide for Vehicle Routing and Scheduling 2026 ORTEC stimuleert AI-gestuurde planning voor meer ",{"id":475,"title":476,"pubDate":477,"logoUrl":478,"thirdParty":11,"imageUrls":479,"orgId":18,"branches":481,"description":483},"6362ddb9-f653-48dc-afb9-89493371549f","Nieuwe software CalQore pakt versnipperde gegevensstroom tussen offerte en productie aan","2026-10-05T11:47:12.777+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fbbbe2d26-551c-4817-949f-572d06875acf\u002Fc8a4790b-aeb1-4376-ae1b-126d39483a30.jpg",[480,480],"https:\u002F\u002Flh3.googleusercontent.com\u002FThzCxfnrdj49vAkjXtnLWsJEl1GHaceF-JwYZkrEVGfumHseqbrtwyNt1Ym1fp9VDmJ3Cz4GZK_kUCUK-aN0WREKaCjo-oMMVXw",[482],{"id":353,"title":354},"Nieuwe software voor plaat-, buis- en profielbewerking verbindt offerte, werkvoorbereiding en productie. Het Bossche softwarebedrijf CalQore heeft op 28 septemb",{"id":485,"title":486,"pubDate":487,"logoUrl":488,"thirdParty":11,"imageUrls":489,"orgId":18,"branches":491,"description":493},"06792159-6d01-4bcc-9b78-07e58ea0086c","Helft van de ouderen voelt zich niet altijd veilig online ","2026-10-05T08:00:00.062+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fbbbe2d26-551c-4817-949f-572d06875acf\u002Ff5a040a8-5352-4ae0-830e-d78e123962ef.jpg",[490,490],"https:\u002F\u002Flh3.googleusercontent.com\u002FJdbAMVPqePB69dysDQS9LmGp0EC_V_AkQFZ-uahDasWVkvwl2K2Aa1RaV20qtlNDB3q6dvf_xQ-RHN1sGRjWZl5sCD3YaUThbA",[492],{"id":368,"title":417},"SeniorWeb en KPN openen inloopmomenten tijdens de Dag van de Digitale Weerbaarheid Op 8 oktober, de Dag van de Digitale Weerbaarheid, kunnen ouderen op 24 locat"]